1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow A2A Pharmaceuticals Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases AO-252 - Solid Tumor Malignancies, Brain Metastases From Solid Tumors | Phase 1 | Recruiting | A2A Pharmaceuticals Inc. | 86 | 2023-11-02 | 2026-08-17 |
Brain Neoplasms (1)
United States (1)